Display Settings:

Format

Send to:

Choose Destination

    Biochem Mol Biol Int. 1993 Apr;29(6):1047-54.

    Effects of the muscarinic agonist oxotremorine on membrane fluidity in rat lymphocytes.

    Tang C, Castoldi AF, Costa LG.

    Department of Environmental Health, University of Washington, Seattle 98195.

    The muscarinic agonist oxotremorine produced a concentration-dependent increase in membrane fluidity in intact viable rat splenic lymphocytes in vitro. This effect was antagonized by atropine, but only at high concentrations (1 mM), while scopolamine was ineffective. Two other muscarinic agonists, carbachol and pilocarpine, did not affect membrane fluidity in lymphocytes. The fluidizing effect of oxotremorine occurred at both 10 and 37 degrees C with a similar time-course. Oxotremorine also increased membrane fluidity in liposomes of DMPC in gel phase, although its effect was less pronounced than in lymphocytes. The data suggest that the fluidization caused by oxotremorine is primarily nonreceptor-mediated and associated with a nonspecific physicochemical effect.

    PMID: 8330013 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Patient drug information

    • Hyoscyamine (Anaspaz®, Cystospaz®, Cystospaz-M®, ...)

      Hyoscyamine is used to control symptoms associated with disorders of the gastrointestinal (GI) tract. It works by decreasing the motion of the stomach and intestines and the secretion of stomach fluids, including acid. H...

    • Pilocarpine (Salagen®)

      Pilocarpine is used to treat dry mouth caused by radiotherapy in people with head and neck cancer and to treat dry mouth in people with Sjogren's syndrome (a condition that affects the immune system and causes dryness of...